Akichika Ozeki
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 06, 2024
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.Takao Takeshima, Hikaru Doi, Satomi Ooba
|May 31, 2023
Lasmiditan in Japanese Patients with Common Migraine Comorbidities or Concomitant Medications: A Post Hoc Safety and Efficacy Analysis from the MONONOFU Study.Shigekazu Kitamura, Noboru Imai, Yuka Tanji
|Oct 20, 2022
Galcanezumab Effects on Migraine Severity and Symptoms in Japanese Patients with Episodic Migraine: Secondary Analysis of a Phase 2 Randomized Trial.Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki
|Sep 22, 2022
Rapid Onset and Sustained Efficacy of Lasmiditan Among Japanese Patients with Migraine: Prespecified Analyses of a Randomized Controlled Trial.Yasuhiko Matsumori, Mika Komori, Yuka Tanji
|Nov 24, 2021
Early Onset and Maintenance Effect of Galcanezumab in Japanese Patients with Episodic Migraine.Hisaka Igarashi, Mamoru Shibata, Akichika Ozeki
|Jan 07, 2021
Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study.Mamoru Shibata, Tomomi Nakamura, Akichika Ozeki
Pageof 1
Frequent Collaborators
3 joint publications
Mika Komori
2 joint publications
Yuka Tanji
1 joint publications
Kaname Ueda
1 joint publications
Russell M Nichols
1 joint publications
Yasuhiko Matsumori
1 joint publications
Fumihiko Sakai
1 joint publications
Shigekazu Kitamura
1 joint publications
Noboru Imai
1 joint publications
Takao Takeshima
